Evrysdi 0.75 mg/mL powder for oral solution, RO7034067
BN44621
Approved small_molecule active
Quick answer
Evrysdi 0.75 mg/mL powder for oral solution, RO7034067 for Spinal Muscular Atrophy (SMA) is a Approved program (small_molecule) at Roche Registration Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Roche Registration Limited
- Indication
- Spinal Muscular Atrophy (SMA)
- Phase
- Approved
- Modality
- small_molecule
- Status
- active